from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2092c/helY

LFCtreatmentdescriptionclass of inhibitor

-1.013

Amikacinug/mL Amikacintranslation

-1.324

Cap5-10ug/mL Capreomycintranslation

-1.379

Rox10-50 ug/mL Roxithromycintranslation

-0.534

SM2-5 ug/mL Streptomycintranslation

-1.866

Tet5-10 ug/mL Tetracyclinetranslation

-0.315

Rif0.2-5ug/mL Rifampicintranscription

-0.623

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.266

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.082

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.130

CPZ10-50 ug/mL Chlorpromazinerespiration

1.477

Clofazimine10-13 ug/mL Clofaziminerespiration

0.235

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.405

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.156

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.367

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.120

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.738

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.660

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.076

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.853

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.054

KCN5-20 ug/mL Potassium cyaniderespiration

-0.732

NaN30.2-2 mM Sodium aziderespiration

1.531

Nigericin50 uM Nigericinrespiration

0.071

TRC10-150 ug/mL Triclosanrespiration

0.347

TRZ10-25 ug/mL Thioridazinerespiration

-1.441

Valinomycin0.5-10 uM Valinomycinrespiration

0.845

ZnSO42 mM ZnSO4respiration

-0.338

menadione6-10 ug/mL Menadionerespiration

-0.078

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.145

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.188

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.037

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.275

NRP_1Non-replicating persistence stage 1dosRassociated

0.208

Amp0.2mg/mL AmpicillincellWall

-0.336

Cephalexin20-100 ug/mL CephalexincellWall

-0.122

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.310

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.143

EMB10-20 ug/mL EthambutolcellWall

-0.025

Eta12-40 ug/mL EthionamidecellWall

0.063

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.014

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.239

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.952

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.519

BZA0.12 mg/mL BenzamidearomaticAmides

-0.042

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.009

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.200

H2O24 mM hydrogen peroxideDNAdamaging

-0.390

Levo10 ug/mL LevofloxacinDNAdamaging

0.122

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.409

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.475

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.040

UVUV-irradiationDNAdamaging

-0.212

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.510

Antimycin12.5-50 ug/mL Antimycin A?

-0.111

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.157

PA_110-50 ug/mL Antitubercular compound PA-1?

0.072

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.862

PA8240.2-2 ug/mL PA-824?

0.509

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.491

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.149

Verapamil50 uM Verapamil?

-0.306

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.475

methoxatin10-20 ug/mL Methoxatin?